MT-RNR1 and adrenal cortex carcinoma: Furthermore, we investigated the expression level of MOTS-c protein in serum samples of patients with adrenal tumors ACC (n = 29), ACA (n = 28), PCC (n = 8) and healthy controls (n = 10) using enzyme-linked immunosorbent assay (ELISA).